393 материалов по теме, собраны автоматически из проверенных источников
The investigational combination of pumitamig and elfetabart drozuntecan (elfe-D) demonstrated a manageable safety profile and encouraging early antitumor activity in patients with small cell lung cancer (SCLC), according to first clinical data from the ongoing Phase Ib/II BNT324-01 trial presented at the International…
Extended-interval dosing regimens of tarlatamab demonstrated efficacy, safety and pharmacokinetic profiles generally consistent with the established every-two-week regimen in patients with previously treated small cell lung cancer (SCLC), according to results from the randomized Phase II DeLLphi-309 study presented at…
Subcutaneous administration of tarlatamab was well tolerated and demonstrated preliminary antitumor activity in patients with previously treated extensive-stage small cell lung cancer (ES-SCLC), according to findings from the phase 1b DeLLphi-308 study presented at the International Association for the Study of Lung…
Lung cancer: Drug approved by FDA for pancreatic cancer may help Medical News Today
Pancreatic cancer drug may also help fight treatment-resistant lung cancer AOL.com
Lung Cancer Treatment Breakthrough? Pancreatic Cancer Drug Shows Early Promise wowo.com
Radical radiotherapy use rising for treating lung cancer AuntMinnie
ALA Expands Lung Cancer Clinical Trial Awareness respiratory-therapy.com
Рак легких с помощью ИИ предложил выявлять депутат Курултая «Астана» телеарнасы
Рак легких с помощью ИИ предложил выявлять депутат Курултая «Астана» телеарнасы
Radiopharm Firm Full-Life to Launch Phase I Lung Cancer Trial in US, Australia GenomeWeb
Detecting lung cancer early is critical to a patient's survival, but how early is early enough? Florida International University math professor and researcher Deborah Goldwasser is uncovering new findings that could identify the mathematical tipping point between curable and terminal cancer. Her work could change how…